The Associates of Bird & Bird's Intellectual Property Group presented the fourth seminar of the In Focus series entitled 'Under the Microscope - IP and Life Sciences' on 19.05.2011.
This seminar considered how the pharmaceutical sector is dealing with the challenge of 'blockbuster' drug patent expiries and there was particular focus on the recent case law developments on supplementary protection certificates (SPCs) which are key to maintaining revenue as long as possible.
The seminar was designed for in-house counsel, lawyers, patent and trade mark agents and those in relevant fields of academia or industry who are either IP practitioners or who seek to be aware of IP issues.
For further information, or to register for future seminars please contact the Events Team at events@twobirds.com or call +44 (0)20 7415 6000.
Attendees of this seminar may click here for access to the materials. Please contact the Chair, below, for further information.
The programme
| Chair |
|
|
|
Chelsea Roche
Welcome and introduction |
|
|
| Speakers |
|
 |
Rachel Fetches
The 'patent cliff' and beyond
- A look at how the pharmaceutical sector is rising to the challenge including SPCs and diversification into orphans, biosimilars and consumer products
|
|
|
Eleanor Root
The 'patent cliff' and beyond
- A look at how the pharmaceutical sector is rising to the challenge including SPCs and diversification into orphans, biosimilars and consumer products
|
|
|
Ewan Grist
Supplementary Protection Certificates: New Combinations and Old Authorisations in SPC applications
- A look at some of the latest key case law
|